|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 31 of 32 found articles
| Title: |
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial |
| Author: |
Pérez-García, José Manuel Cortés, Javier Ruiz-Borrego, Manuel Colleoni, Marco Stradella, Agostina Bermejo, Begoña Dalenc, Florence Escrivá-de-Romaní, Santiago Calvo Martínez, Lourdes Ribelles, Nuria Marmé, Frederik Cortés, Alfonso Albacar, Cinta Gebhart, Geraldine Prat, Aleix Kerrou, Khaldoun Schmid, Peter Braga, Sofia Di Cosimo, Serena Gion, Maria Antonarelli, Gabriele Popa, Crina Szostak, Emilia Alcalá-López, Daniel Gener, Petra Rodríguez-Morató, Jose Mina, Leonardo Sampayo-Cordero, Miguel Llombart-Cussac, Antonio |
| Appeared in: |
Lancet |
| Paging: | Volume 403 () nr. 10437 pages 1649-1659 |
| Year: |
2024 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 31 of 32 found articles
| << previous | next >> |